After completing this activity, pharmacists should be able to:
- Recognise common symptoms associated with colorectal cancer
- Describe treatments offered to patients with colorectal cancer
- State the bowel cancer screening process for average risk individuals in Australia
- Identify prominent side effects associated with chemotherapy and monoclonal antibodies used to treat colorectal cancer
2016 Competency Standards: 3.2, 3.6
Accreditation number: A2011RP2 Accreditation expires: 31/10/2022
This activity has been accredited for 1 hour of Group One CPD (or 1 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which may be converted to 1 hour of Group Two CPD (or 2.0 CPD credits) upon successful completion of the associated assessment activity.